| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/28/2005 | WO2003100076A3 Pna probes, probe sets, method and kits pertaining to the determination of listeria |
| 04/28/2005 | WO2003095971A3 Posh nucleic acids, polypeptides and related methods |
| 04/28/2005 | WO2003087389A3 Biologic modulations with nanoparticles |
| 04/28/2005 | WO2003062792A3 Methods for determining drug responsiveness |
| 04/28/2005 | WO2003044170A3 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 04/28/2005 | WO2003041568A3 A three-dimensional matrix for producing living tissue equivalents |
| 04/28/2005 | WO2003004991A3 Method for detection, quantitation and breakpoint cluster region determination of fusion transcripts |
| 04/28/2005 | WO2002092768A3 Novel alanine transaminase enzyme and methods of use |
| 04/28/2005 | WO2002072013A8 Method of treating malignancies through induction of blood immune responses |
| 04/28/2005 | WO2002004676A3 Composite and averaged hybridizations |
| 04/28/2005 | US20050091711 isolated by identifying and analyzing genes of Arabidopsis thaliana; trichome is involved in secretion and excretion from the surface of a plant body |
| 04/28/2005 | US20050091710 a transposon-like element specifically present in the rye genome but not present in the wheat genome, for the purpose of breading wheat exhibiting resistance to disease and environmental stress |
| 04/28/2005 | US20050091703 Nonhuman model animal of th2-mediated hyperimmune response |
| 04/28/2005 | US20050090671 for human telomeres/telomerases; drug screening |
| 04/28/2005 | US20050090658 Comprises polymorphic variations/point mutations linked to cation channel dysfunctions; genetic engineering; treansgenic animal; antibody |
| 04/28/2005 | US20050090647 Pharmaceutical compositions for treating arthritis and inflammatory disease |
| 04/28/2005 | US20050090607 Silicone composition for biocompatible membrane |
| 04/28/2005 | US20050090441 inducing prolonged in vivo gene expression in mammal by contacting nonmuscular tissue with a nucleic acid, a histone, and an amphipathic compound; animal models: |
| 04/28/2005 | US20050090434 Novel therapeutic targets in cancer |
| 04/28/2005 | US20050090005 Apparatus for culture, process for preparing apparatus for culture, and culturing method |
| 04/28/2005 | US20050089984 Having a specific amino acid sequence, especially fused to a heterologous polypeptide; induces apoptosis |
| 04/28/2005 | US20050089966 Chemically modified enzymes with multiple charged variants |
| 04/28/2005 | US20050089964 Produces bioluminescence of Phrixotrhix vivianii (beetles) when expressed in Escherichia; recombinant vectors, host cells |
| 04/28/2005 | US20050089957 Chimera; immunoglobuins; antibodies; host cells; immunohistochemistry |
| 04/28/2005 | US20050089948 Contains mucolytic agent (cysteine, glutathione, N-acetyl-cysteine, N-isobutyrylcysteine) and bactericide (sodium hydroxide, sodium citrate); centrifuging; reduces cross-contamination |
| 04/28/2005 | US20050089947 Bioassays for determining if an microorganism produces AmpC beta-lactamase |
| 04/28/2005 | US20050089946 Bioassay; immunoassay; fluorescent dyes binds flexible peptide; self-quenching |
| 04/28/2005 | US20050089945 Abeta 42 lowering agents |
| 04/28/2005 | US20050089944 High sensitivity amperometric biosensor with side-to-side hybrid configuration |
| 04/28/2005 | US20050089941 Drug screening; SCFV fragments; polyacrylamide gel electrophoresis |
| 04/28/2005 | US20050089940 Measuring receptor homodimerization |
| 04/28/2005 | US20050089938 For treatment of epilepsy, hypertension, angina pectoris, cerebral ischaemia, Parkinson's disease, insulin-dependent diabetes, and/or Lambert-Eaton myasthenic syndrome |
| 04/28/2005 | US20050089924 Increasing the sensitivity of assays while decreasing the sample volume by integrating aluminum-coated reflective sidewalls mirrors into microchannels used in assays of fluorescently tagged molecules; increasing the signal-to-noise ratio of the optical signal using geometrical cross-section shapes |
| 04/28/2005 | US20050089922 Inhibiting nucleic acid synthesis, comprising a nucleic acid inhibitor that is capable of binding or has affinity to an enzyme with polymerase activity; an oligonucliotide inhibiting or preventing nucleic acid synthesis, amplification or sequencing; polymerase inhibitors; viricides; HIV |
| 04/28/2005 | US20050089920 Determination of haploid genotype of sample; obtain nucleotide sequences, detect polymorphism, classify genotype |
| 04/28/2005 | US20050089919 In vitro method of measuring the expression level of the human gene for early lymphocyte activation antigen CD69 exon1 (CD69) in the biological sample and providing a diagnosis and an increased susceptibility if the expression level is increased and vice versa; accurate and safe intervention |
| 04/28/2005 | US20050089918 In-situ cell extraction and assay method |
| 04/28/2005 | US20050089917 Novel kinases and uses thereof |
| 04/28/2005 | US20050089916 Selecting probes for multiplexed hybridization analysis of genes with multiple polymorphic regions by eliminating probes generating ambiguities, setting thresholds so only probe-target interactions above the threshold are considered positive and selectively adding probes until ambiguities are eliminated |
| 04/28/2005 | US20050089915 Hybridization-based fluorescence assay |
| 04/28/2005 | US20050089914 Based on the risk of arteriosclerosis inherent to a combination of plural genetic polymorphisms where the combination of plural genetic polymorphisms includes a significant positive correlation with the carotid arterial intima-media thickness; accuracy;analysis kits; medical diagnosis; data processing |
| 04/28/2005 | US20050089912 Nucleic acids having polynucleotide sequences to encode two novel splice variant isoforms of nuclear factor kappa-B, subunit 1 (NFKB1) called NFKB1sv1 and NFKB1sv2; screening for agonist and antagonist ligands to bind to the new isoforms; antiinflammatory, - carcinogenic agents; AIDS;lupus; viricides |
| 04/28/2005 | US20050089911 87 human secreted proteins |
| 04/28/2005 | US20050089910 DNA polymerase having ability to reduce innate selective discrimination against fluorescent dye-labeled dideoxynucleotides |
| 04/28/2005 | US20050089909 Diagnosing osteoporosis and paget's diseases via identifying variable numbers of tandem repeats in allelic sequences coding parathyroid hormone related peptide (PTHrP) |
| 04/28/2005 | US20050089908 An optimized variant of cyan fluorescent protein (oCFP) containing an amino acid other than tyrosine at position 145. |
| 04/28/2005 | US20050089906 Haplotype estimation method |
| 04/28/2005 | US20050089905 Polymorphisms associated with ion-channel disease |
| 04/28/2005 | US20050089904 Allele-specific sequence variation analysis |
| 04/28/2005 | US20050089902 Methods and compositions for siRNA expression |
| 04/28/2005 | US20050089899 Analyzing differential gene expression associated with breast tumor, based on the analysis of the over-expression of polynucleotide sequences such as ERBB2, GATA4, and CDH15 in a sample or cell line |
| 04/28/2005 | US20050089898 Method and materials for quaternary amine catalyzed bisulfite conversion of cytosine to uracil |
| 04/28/2005 | US20050089897 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 04/28/2005 | US20050089896 Method to control tumor progression and invasiveness |
| 04/28/2005 | US20050089895 Compositions and methods for prognosis and therapy of liver cancer |
| 04/28/2005 | US20050089894 Controller programmed for data processing; nucleic acid measurement and polymerase chain reaction module; extracting nucleic acids from cells; thermocycling; mass spectrometry |
| 04/28/2005 | US20050089891 Extracting genomic DNA samples;synthesizing PCR primers and fluorescent labeled to form mixture; data processing |
| 04/28/2005 | US20050089889 Kits for detecting, classifying, or quantitating components in mixture of nucleic acids, such as a transcriptome; data processing |
| 04/28/2005 | US20050089887 Novel human ion channel proteins |
| 04/28/2005 | US20050089885 IRF6 polymorphisms associated with cleft lip and/or palate |
| 04/28/2005 | US20050089880 Which have a SET domain, such deregulation being of importance in certain cancers; SET domains are protein methyltransferase enzymes |
| 04/28/2005 | US20050089879 DNA sequences coding for a Delta 5-desaturase, wherein the enzymatic activity is specific solely for dihomo-gamma-linolenic acid; transgenic plants |
| 04/28/2005 | US20050089878 Determining a plurality of functional annotation scores for a query protein and comparing these functional annotation scores to distributions of similar functional annotation scores derived from a plurality of reference proteins |
| 04/28/2005 | US20050089877 Robust genotyping method using DNA chip and DNA chip used therein |
| 04/28/2005 | US20050089876 Human E3alpha ubiquitin ligase family |
| 04/28/2005 | US20050089875 Quantitative analysis of expression profiling information produced at various stages of an amplification process |
| 04/28/2005 | US20050089874 Amplification of signal using a bead-based oligonucleotide assay |
| 04/28/2005 | US20050089872 Nucleic acid molecules encoding annexins from plants |
| 04/28/2005 | US20050089871 G protein-related kinase mutants in essential hypertension |
| 04/28/2005 | US20050089870 Oligonucleotide-immobilized substrate used for detecting presence or absence of methylation of cytosine in nucleotide sequence sample without the need of numerous oligonucleotides |
| 04/28/2005 | US20050089868 Modulators of tissue regeneration |
| 04/28/2005 | US20050089864 Aptamer based fluorescent reporters that function based on a switch from DNA/DNA duplex conformation to DNA/target conformation; signal generated when there is a dissociation of the duplex structure which occurs in presence of a target |
| 04/28/2005 | US20050089862 Polymerase Chain Reaction (PCR); analyzing differential gene expression patterns; use e.g. for diagnosis of Alzheimer's disease; high throughput approach; determining the relative copy number of a group of target nucleic acid molecules present in a sample; preclinical noninvasive diagnosis |
| 04/28/2005 | US20050089860 Oligonucleotide sequences free from mishybridization and method of designing the same |
| 04/28/2005 | US20050089857 Nucleic acid detection method and system thereof |
| 04/28/2005 | US20050089856 Using variation in polymerase chain reaction products as diagnostic tool in identifying hydrolase variants; identifying agents for prevention and treatment of epilepsy, nervous system and cardiovascular disorders |
| 04/28/2005 | US20050089855 Expression vector comprising nucleotide sequences coding glycine transport protein for use in identifying modulator for treatment and prevention of nervous system and psychiatric disorders |
| 04/28/2005 | US20050089853 Method |
| 04/28/2005 | US20050089852 Microarray for use in identifying polymorphisms in hepatocyte nuclear factor-1, amylin, glucokinase and/or mitochondrial DNA which are associated with pancreatic disorders in individuals of asian descent |
| 04/28/2005 | US20050089851 Polynucleotides for use as tags and tag complements, manufacture and use thereof |
| 04/28/2005 | US20050089850 Genotyping by liquid chromatographic analysis of short nucleic acid fragments |
| 04/28/2005 | US20050089848 Nucleotide sequences coding islet cell antigen-2 (IA21C) for use as diagnostic tools in detection of insulin-dependent diabetes mellitus |
| 04/28/2005 | US20050089847 Short chain dehydrogenases/reductases(sdr) |
| 04/28/2005 | US20050089841 Induction of a Th1-like response in vitro |
| 04/28/2005 | US20050089839 Assay |
| 04/28/2005 | US20050089447 Base sequence detecting electrode, base sequence detecting device and base sequence detecting method |
| 04/28/2005 | US20050087000 Sensor and method for measuring the areal density of magnetic nanoparticles on a micro-array |
| 04/28/2005 | CA2551049A1 In vitro method for the diagnosis of cardiovascular functionality of bone marrow precursor cells (bmp) and/or blood-derived circulating precursor cells (bdp) |
| 04/28/2005 | CA2548551A1 Shc proteins as therapeutic targets in proliferative diseases |
| 04/28/2005 | CA2546623A1 Cystatin c as an antagonist of tgf-.beta. and methods related thereto |
| 04/28/2005 | CA2543033A1 Direct nucleic acid detection in bodily fluids |
| 04/28/2005 | CA2542795A1 Systems and methods for assessing neuronal degeneration |
| 04/28/2005 | CA2542787A1 Method and kit for primer based multiplex amplification of nucleic acids |
| 04/28/2005 | CA2542773A1 Microfluidic device for carrying out a reaction |
| 04/28/2005 | CA2542674A1 Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications |
| 04/28/2005 | CA2542629A1 Ntrk1 genetic markers associated with age of onset of alzheimer's disease |
| 04/28/2005 | CA2542595A1 Method and apparatus for estimation of the electrostatic affinity between molecules using a basis expansion |
| 04/28/2005 | CA2542456A1 Lead molecule cross-reaction prediction and optimization system |
| 04/28/2005 | CA2542447A1 Method and apparatus for analysis of molecular combination based on computations of shape complementarity using basis expansions |
| 04/28/2005 | CA2542443A1 Methods and compositions related to a matrix chip |